erythrosine has been researched along with Disease Exacerbation in 17 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze the appearance and disappearance of microaneurysms in different phases of fluorescein angiography." | 7.69 | Early versus late staining of microaneurysms in fluorescein angiography. ( Hellstedt, TJ; Immonen, IJ; Jalli, PY, 1997) |
| "To analyze the appearance and disappearance of microaneurysms in different phases of fluorescein angiography." | 3.69 | Early versus late staining of microaneurysms in fluorescein angiography. ( Hellstedt, TJ; Immonen, IJ; Jalli, PY, 1997) |
| "Treatment with diapocynin also significantly improved locomotor activity, restored dopamine and its metabolites, and protected dopaminergic neurons and their nerve terminals in this pre-clinical model of PD." | 1.38 | Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. ( Anantharam, V; Dranka, BP; Ghosh, A; Joseph, J; Kalyanaraman, B; Kanthasamy, A; Kanthasamy, AG; Srivastava, P, 2012) |
| "The diagnosis of root caries, in particular the judgment of the activity of a visually observed lesion, is difficult." | 1.29 | Evaluation of sodium fluorescein for quantitative diagnosis of root caries. ( Arends, J; ten Bosch, JJ; Tsuda, H; van der Veen, MH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Mullins, TP | 1 |
| Tan, WS | 1 |
| Carter, DA | 1 |
| Gallo, LA | 1 |
| Wang, T | 1 |
| Wen, Y | 1 |
| Fan, X | 1 |
| Li, K | 1 |
| Su, W | 1 |
| Li, M | 1 |
| Chen, CJ | 1 |
| Li, YY | 1 |
| Lai, LY | 1 |
| Zhang, MM | 1 |
| Liu, SJ | 1 |
| Fichna, J | 1 |
| Peng, A | 1 |
| Hao, CM | 1 |
| Gu, Y | 1 |
| Lin, SY | 1 |
| Prager, EM | 1 |
| Aroniadou-Anderjaska, V | 1 |
| Almeida-Suhett, CP | 1 |
| Figueiredo, TH | 1 |
| Apland, JP | 1 |
| Rossetti, F | 1 |
| Olsen, CH | 1 |
| Braga, MF | 1 |
| Siu, SY | 1 |
| Dyment, NA | 1 |
| Rowe, DW | 1 |
| Sundberg, JP | 1 |
| Uitto, J | 1 |
| Li, Q | 1 |
| Molitoris, BA | 1 |
| Chen, B | 1 |
| Friedman, B | 1 |
| Cheng, Q | 1 |
| Tsai, P | 1 |
| Schim, E | 1 |
| Kleinfeld, D | 1 |
| Lyden, PD | 1 |
| Yao, Y | 1 |
| Tsirka, SE | 1 |
| do Nascimento, AL | 1 |
| Dos Santos, NF | 1 |
| Campos Pelágio, F | 1 |
| Aparecida Teixeira, S | 1 |
| de Moraes Ferrari, EA | 1 |
| Langone, F | 1 |
| Ghosh, A | 1 |
| Kanthasamy, A | 1 |
| Joseph, J | 1 |
| Anantharam, V | 1 |
| Srivastava, P | 1 |
| Dranka, BP | 1 |
| Kalyanaraman, B | 1 |
| Kanthasamy, AG | 1 |
| Yi, ZC | 1 |
| Liu, YZ | 1 |
| Li, HX | 1 |
| Yin, Y | 1 |
| Zhuang, FY | 1 |
| Fan, YB | 1 |
| Wang, Z | 1 |
| van Vliet, EA | 1 |
| da Costa Araújo, S | 1 |
| Redeker, S | 1 |
| van Schaik, R | 1 |
| Aronica, E | 1 |
| Gorter, JA | 1 |
| Hall, ED | 1 |
| Bryant, YD | 1 |
| Cho, W | 1 |
| Sullivan, PG | 1 |
| van der Veen, MH | 1 |
| Tsuda, H | 1 |
| Arends, J | 1 |
| ten Bosch, JJ | 1 |
| Jalli, PY | 1 |
| Hellstedt, TJ | 1 |
| Immonen, IJ | 1 |
| Hietala, EL | 1 |
| Autio, J | 1 |
| Larmas, M | 1 |
| Kobayashi, Y | 1 |
| Goto, S | 1 |
| Tanno, T | 1 |
| Yamazaki, M | 1 |
| Moriya, H | 1 |
1 review available for erythrosine and Disease Exacerbation
| Article | Year |
|---|---|
Rethinking CKD Evaluation: Should We Be Quantifying Basal or Stimulated GFR to Maximize Precision and Sensitivity?
Topics: Animals; Biomarkers; Creatinine; Diabetic Nephropathies; Dietary Proteins; Disease Progression; Earl | 2017 |
16 other studies available for erythrosine and Disease Exacerbation
| Article | Year |
|---|---|
Validation of non-invasive transcutaneous measurement for glomerular filtration rate in lean and obese C57BL/6J mice.
Topics: Animals; Body Weight; Diagnostic Techniques, Urological; Diet, High-Fat; Disease Progression; Fluore | 2020 |
Myeloid-derived suppressor cells suppress CD4+ T cell activity and prevent the development of type 2 diabetes.
Topics: Adult; Animals; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Diabetes Mellitus, Type 2 | 2018 |
Acid loading stimulates rat glomerular mesangial cells proliferation through Na(+)-H (+) exchanger isoform 1 (NHE1)-dependent pathway.
Topics: Acidosis; Amiloride; Animals; Blotting, Western; Cell Cycle; Cell Proliferation; Disease Progression | 2013 |
The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior.
Topics: Acetylcholinesterase; Animals; Anxiety; Basolateral Nuclear Complex; Cholinesterase Inhibitors; Dise | 2014 |
Variable patterns of ectopic mineralization in Enpp1asj-2J mice, a model for generalized arterial calcification of infancy.
Topics: Animals; Anthraquinones; Connective Tissue; Demeclocycline; Disease Progression; Fluoresceins; Fluor | 2016 |
Severe blood-brain barrier disruption and surrounding tissue injury.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Cerebral Arteries; Dextrans; Disea | 2009 |
The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage.
Topics: Analysis of Variance; Animals; Antigens, Ly; Brain Edema; Calcium-Binding Proteins; Cerebral Hemorrh | 2012 |
Neuronal degeneration and gliosis time-course in the mouse hippocampal formation after pilocarpine-induced status epilepticus.
Topics: Analysis of Variance; Animals; Cell Death; Disease Models, Animal; Disease Progression; Fluoresceins | 2012 |
Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Chromatography, High Pressure | 2012 |
Tellimagrandin I enhances gap junctional communication and attenuates the tumor phenotype of human cervical carcinoma HeLa cells in vitro.
Topics: Antineoplastic Agents; Connexin 43; Disease Progression; Dose-Response Relationship, Drug; Drugs, Ch | 2006 |
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.
Topics: Acute Disease; Adolescent; Adult; Albumins; Animals; Blood-Brain Barrier; Brain; Chronic Disease; Co | 2007 |
Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods.
Topics: Animals; Brain Injuries; Cerebral Cortex; Copper; Disease Models, Animal; Disease Progression; Fluor | 2008 |
Evaluation of sodium fluorescein for quantitative diagnosis of root caries.
Topics: Dentin; Dentin Permeability; Disease Progression; Evaluation Studies as Topic; Fluorescein; Fluoresc | 1996 |
Early versus late staining of microaneurysms in fluorescein angiography.
Topics: Adult; Aged; Aneurysm; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Progression; Female; | 1997 |
The effect of early weaning on dentin formation and dentinal caries in rats.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Coloring Agents; Dental Caries; Dental Enamel; | 1997 |
Regional variations in the progression of bone loss in two different mouse osteopenia models.
Topics: Aging; Animals; Body Weight; Bone Development; Bone Diseases, Metabolic; Disease Progression; Female | 1998 |